Meeting to be held in Orlando on April 17 hosted by Piper Sandler.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NRIX:
- Nurix Therapeutics Presents Data at the American Association for Cancer Research (AACR) Annual Meeting Highlighting Activity of its BTK Targeted Protein Degraders, NX-2127 and NX-5948, against a Broad Range of BTKi Resistance Mutations
- Nurix Therapeutics advances almost 4% after reporting Q1 results and update
- Nurix Therapeutics reports Q1 EPS (86c), consensus (87c)
- Nurix Therapeutics Reports First Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
- Nurix Therapeutics management to meet with Piper Sandler